Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
A daily pill for weight loss has officially arrived in the U.S.
Jan 6, 2026
0
0
A daily pill for weight loss has officially arrived in the U.S.
Jan 6, 2026
0
0
Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until serious damage has occurred. While diabetes and high blood pressure are well-known culprits, researchers ...
Jan 6, 2026
0
61
Many autistic people face challenges in their daily life while navigating a world made for neurotypical people.
Jan 6, 2026
0
1
Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly observing how muscle and ...
Jan 6, 2026
0
0
Obtaining clearer functional MRI data about the brain and its disorders is possible using artificial intelligence, according to Boston College researchers who report in Nature Methods that they have developed an AI-assisted ...
Jan 6, 2026
0
8
Obesity is a growing national health crisis, with nearly 40% of U.S. adults affected and about 10% having a severe form of the disease. Although weight-loss drugs are surging in popularity and have reshaped conversations ...
Jan 5, 2026
0
3
As New Year's resolutions roll around again, the vow to lead a more active lifestyle often tops the list—but it doesn't have to be tough to do, says a University of Alberta physical activity expert.
Jan 5, 2026
0
0
A recent lawsuit filed in San Diego Superior Court alleges that Sharp HealthCare recorded conversations between doctors and their patients without written consent, using the information to document visits with an artificial ...
21 hours ago
0
1
Glossy social media ads promising "lunchtime fat removal" and "freckle-sized" scars draw thousands of patients to cosmetic surgery chains.
Jan 5, 2026
0
0
A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared ...
Jan 5, 2026
0
0